Physician Wealth Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Physician Wealth Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39K	Hold	53	–	–	﹤0.01%	1274
2026 Q1	$2.55K	Buy	53 +22	+71%	+$975	﹤0.01%	1245
2025 Q4	$1.28K	Hold	31	–	–	﹤0.01%	1494
2025 Q3	$1.2K	Hold	31	–	–	﹤0.01%	1467
2025 Q2	$858	Buy	+31	New	+$789	﹤0.01%	1523

Other funds holding KNSA

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

Physician Wealth Advisors's KNSA Position: Q2 2026 in Review

Physician Wealth Advisors held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 53 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Physician Wealth Advisors first reported a position in KNSA in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Physician Wealth Advisors held 53 shares of Kiniksa Pharmaceuticals worth $3.39K as of Q2 2026.
Physician Wealth Advisors left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1274 holding.
Physician Wealth Advisors first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
61 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.